Agreement Expands Access to Pioneering Proteomics Technology Across the U.S. and Canadian Markets BRANFORD, Conn. / Nov 20, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor ® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced... Read More

Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing BRANFORD, Conn. / Nov 20, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino... Read More

Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease BRANFORD, Conn. & BLOOMINGTON, Minn. / Nov 20, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to... Read More

Combined Teams Aim to Deliver Novel Proteomics Platform in Under Two Years BRANFORD, Conn. / Nov 20, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si’s novel proteomics platform, Proteus™. Planet Innovation has a team of over four... Read More

BRANFORD, Conn. / Nov 18, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 340,460 restricted stock units (“RSUs”) to a new employee under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended... Read More

BRANFORD, Conn. / Nov 13, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sullivan’s prestigious 2024 Technology Innovation Leadership Award in North America. This award recognizes QSI’s groundbreaking work in developing the Platinum ® instrument, the first benchtop sequencer capable of... Read More

Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch BRANFORD, Conn. / Nov 12, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio... Read More

Published Preprint Demonstrates Platinum’s Capability to Discriminate Peptide Variants with Single Amino Acid Resolution BRANFORD, Conn. / Nov 07, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication on BioRxiv, from Dr. Gloria Sheynkman at the University of Virginia School of Medicine. In... Read More

BRANFORD, Conn. / Nov 05, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13 th , at 8:45 AM... Read More

BRANFORD, Conn. / Oct 31, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New York City on November 20 th , 2024. Quantum-Si’s management team will provide updates on the Company’s evolving technology roadmap, emerging applications for protein sequencing and the... Read More

"From Prediction to Protein: Validating Transcriptomics Data with Quantum-Si’s Next-Generation Protein Sequencing™ Technology" BRANFORD, Conn. / Oct 30, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, where it will host a sponsored talk on... Read More

BRANFORD, Conn. / Oct 23, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the third quarter of 2024 on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:00 AM ET. Individuals... Read More

BRANFORD, Conn. / Oct 17, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted an aggregate of 385,983 restricted stock units (“RSUs”) to five new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive... Read More

BRANFORD, Conn. / Oct 10, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its participation at the Human Proteome Organization (HUPO) World Congress 2024 in Dresden, Germany. As a leader in Next-Generation Protein Sequencing™ (NGPS), Quantum-Si will be joined by prominent researchers to present data showcasing advancements... Read More

BRANFORD, Conn. / Sep 24, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced an upcoming webinar that will explore the integration of top-down mass spectrometry (TD-MS) with Quantum-Si’s groundbreaking Platinum ® instrument. The event, titled "Integrating Top-Down Mass Spectrometry and Single-Molecule Sequencing for Proteoform... Read More

BRANFORD, Conn. / Sep 19, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New York City on November 20 th , 2024. Quantum-Si’s management team will provide updates on the Company’s market opportunities, provide deeper insights into the technology roadmap including new... Read More

BRANFORD, Conn. / Sep 04, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based biotech unleashing the potential of genetic medicines with novel delivery vehicles, has integrated the Platinum® Next-Generation Protein Sequencer™ (“NGPS”) into their platform for developing novel gene therapies with... Read More

BRANFORD, Conn. / Aug 27, 2024 / Business Wire / Please replace the release with the following corrected version due to multiple revisions. The updated release reads: QUANTUM-SI ANNOUNCES NEW EXECUTIVE TEAM MEMBERS TO ACCELERATE THE EVOLUTION OF THE COMPANY INTO A LEADING PROTEOMIC TOOL PROVIDER Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that... Read More

BRANFORD, Conn. / Aug 27, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 16, 2024, John Vieceli, Ph.D. has been named Chief Product Officer and Lindsay Thompson has been named Chief Human Resources Officer. “I am pleased to... Read More

BRANFORD, Conn. / Aug 26, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in the 26 th Annual H.C. Wainwright Global Investment Conference taking place in New York City September 9-11, 2024. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat on Tuesday,... Read More

Announces Release of Version 3 Sequencing Kit Announces Two Additional Kit Launches Expected by End of 2024 BRANFORD, Conn. / Aug 07, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2024. Press Release Highlights Reported revenue of $622,000 in the second quarter of... Read More

BRANFORD, Conn. / Jul 30, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in the Canaccord Genuity 44 th Annual Growth Conference taking place in Boston August 13-15, 2024. Jeff Hawkins, Quantum-Si's Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will participate in a... Read More

BRANFORD, Conn. / Jul 17, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the second quarter of 2024 on Wednesday, August 7, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals... Read More

BRANFORD, Conn. / Jun 10, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a presentation by Gloria Sheynkman, Ph.D., Assistant Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia at the Festival of Genomics and Biodata conference being held in Boston on June 12-13, 2024.... Read More

BRANFORD, Conn. / May 31, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia’s lab will present a poster developed in collaboration with... Read More

BRANFORD, Conn. / May 30, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Charles (“Chuck”) Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr.... Read More

Executed Full Commercial Launch of Platinum® Instrument Reaffirms Full Year 2024 Financial Guidance BRANFORD, Conn. / May 09, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue of $457,000 in the first quarter of 2024... Read More

BRANFORD, Conn. / Apr 30, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum ® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the Platinum ® instrument. “A core component of our Platinum Analysis Software is a... Read More

BRANFORD, Conn. / Apr 18, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested... Read More

BRANFORD, Conn. / Mar 21, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced the appointment of Paula Dowdy , a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. Ms. Dowdy currently serves on the Board of Directors for SPT... Read More

BRANFORD, Conn. / Mar 07, 2024 / Business Wire / Quantum-Si Incorporated (NASDAQ: QSI): WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated , will showcase its Next-Generation Protein Sequencing™ instrument, Platinum ® , and recent enhancements at the 20 th Anniversary US HUPO Conference in Portland, Oregon on March 9-13. Additionally, researchers will present data from Platinum and highlight how protein... Read More

Finalizing Commercial Readiness for Expected Full Commercial Launch by the End of Q1 2024 Releases Full Year 2024 Financial Guidance BRANFORD, Conn. / Feb 29, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced financial results for the fourth quarter and full year ended December 31, 2023. Press Release Highlights Recorded... Read More

BRANFORD, Conn. / Feb 09, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, February 29, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.... Read More

Addition of another amino acid recognizer combined with improvements in surface chemistry, reagents and software will offer Platinum users greater sequencing output and coverage per sample BRANFORD, Conn. / Feb 05, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the launch of new platform enhancements for Platinum®, with the... Read More

BRANFORD, Conn. / Jan 18, 2024 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company’s protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich... Read More

BRANFORD, Conn. / Dec 12, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new international distributor as demand grows for its first-to-market next-generation protein sequencing™ instrument, Platinum™. 3Genes Distribution a.s., a prominent technology provider specializing in life... Read More

BRANFORD, Conn. / Nov 15, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si’s groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This agreement... Read More

BRANFORD, Conn. / Nov 09, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum... Read More

BRANFORD, Conn. / Nov 08, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it has received the “Proteomics Company of the Year” award from the BioTech Breakthrough Awards as part of the program’s 2023 award recipients for its first of a kind protein sequencing instrument. “Since the groundbreaking introduction of Platinum™,... Read More

BRANFORD, Conn. / Nov 01, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in two upcoming investor conferences: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum 6 th Annual Evercore ISI HealthCONx Conference About the Canaccord Genuity MedTech Diagnostics and Digital... Read More

BRANFORD, Conn. / Oct 31, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will showcase next-generation benchtop protein sequencing instrument, Platinum™, and the Company’s vision to transform genomics and proteomics research, at the American Society of Human Genetics (ASHG) conference, in Washington, D.C., November 1-5.... Read More

BRANFORD, Conn. / Oct 17, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the third quarter 2023 on Thursday, November 9, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals... Read More

Remarks from Senior Vice President of Product Development John Vieceli will highlight the Company’s scalable next-generation Protein Sequencing™ technology to analyze the proteome with single amino acid resolution BRANFORD, Conn. / Oct 03, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the Company and Senior Vice President... Read More

BRANFORD, Conn. / Sep 21, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries... Read More

BRANFORD, Conn. / Aug 22, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Platinum™, the world’s first next-generation protein sequencing instrument, has been honored in Fast Company ’s Innovation by Design Awards for 2023 in the Products category. The Innovation by Design Awards, which can be found in the September... Read More

BRANFORD, Conn. / Aug 16, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted a non-qualified stock option award to purchase an aggregate of 200,000 shares of its Class A common stock to one new employee under the Company’s previously adopted... Read More

BRANFORD, Conn. / Aug 14, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted non-qualified stock option awards to purchase an aggregate of 739,750 shares of its Class A common stock to 8 new employees under the Company’s previously adopted... Read More

BRANFORD, Conn. / Aug 07, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum™ instruments. Strengthened the Board of... Read More

BRANFORD, Conn. / Jul 26, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in the Canaccord Genuity 43rd Annual Growth Conference taking place at the InterContinental Boston Hotel on August 7-10, 2023. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in the panel discussion... Read More

BRANFORD, Conn. / Jul 18, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the second quarter 2023 on Monday, August 7, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET. Individuals... Read More

BRANFORD, Conn. / Jun 21, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Johan Denecke as Senior Vice President of Operations, effective June 20, 2023. Mr. Denecke will be responsible for scaling up production and driving operational and quality excellence in support of the commercialization of... Read More

World-class laboratory and office space underpins the scaling of Quantum-Si’s operational and development capabilities in support of its goal to revolutionize protein sequencing. Company continues rich 10 year history in Connecticut with new facility through 2029 BRANFORD, Conn. / Jun 07, 2023 / Business Wire / Quantum-Si- Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™,... Read More

BRANFORD, Conn. / May 25, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023. Quantum-Si’s management will present on Thursday, June 8, 2023 at 8:30 AM ET. A live and archived webcast of... Read More

GUILFORD, Conn. / May 22, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors. “Jack brings a wealth of experience in commercial and operational leadership. His industry insights will be invaluable as we broaden our product portfolio and... Read More

GUILFORD, Conn. / May 15, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the election of Scott Mendel, former President and Chief Executive Officer of GenMark Diagnostics, Inc., to its Board of Directors. Mr. Mendel has more than 30 years of financial and operational leadership experience in the life sciences, diagnostics... Read More

Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8% This was the Company’s first quarter of revenue generated on the sale of Platinum TM instruments and kits Expect revenue to accelerate in the second half of 2023 based on robust business funnel GUILFORD, Conn. / May 11, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM ,... Read More

Appointment positions company for strategic growth in next-generation protein sequencing GUILFORD, Conn. / May 02, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023. Mr. Keyes brings more than 25 years of experience in senior financial... Read More

Quantum-Si Strengthens Commercial, Operations, and Development Teams to Accelerate the Commercial Advancement of the Platinum™ Protein Sequencing Platform GUILFORD, Conn. / Apr 24, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President of Demand Generation and... Read More

GUILFORD, Conn. / Apr 20, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the first quarter 2023 on Thursday, May 11, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals... Read More

GUILFORD, Conn. / Apr 14, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced it will be presenting a poster on a new method for detection of arginine post-translational modifications (PTMs) using Platinum™, the world’s first next-generation single-molecule protein sequencing platform, at the American Association for Cancer... Read More

GUILFORD, Conn. / Mar 24, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will be participating in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference to be held on Thursday, April 6, 2023. Patrick Schneider, Ph.D., Quantum-Si’s... Read More

GUILFORD, Conn. / Feb 13, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company TM , today announced that it will report financial results for the fourth quarter and full year 2022 before market open on Monday, March 6, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at... Read More

Company Announces Commercial Shipments of Protein Sequencing System, Reveals New Partnerships, and Reaffirms Commitment to Financial Discipline Launched in December 2022, Platinum is the First Commercially Available Next-Generation Single-Molecule Protein Sequencing System Looking to Unlock the Proteome One Amino Acid at a Time Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein... Read More

Protein Enrichment Kits to Enable Deep Interrogation of Proteoforms through Protein Sequencing Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it entered into a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products with an extensive portfolio of over 20,000 antibodies against more... Read More

Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery Key Takeaways This partnership combines Quantum-Si’s expertise in single molecule protein sequencing with Biovista’s AI visualization technology to facilitate faster and more efficient protein drug target discovery. Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”),... Read More

Dec. 22, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis, San Francisco, CA on January 9-12, 2023. Quantum-Si’s management will present on Thursday, January 12 at 10:30 am Pacific Standard Time. The discussions will... Read More